PrEP failures in African programmes are rare, but some are happening in people with good adherence
Viral suppression in Uganda improved by more viral load tests, done faster
Long-acting injectable HIV treatment is feasible, even during COVID-19
Twice-a-year injected drug shows promise for first-line HIV treatment
Adolescent-centred interventions lead to a 30-percentage-point increase in viral suppression in Namibia, and a 20-percentage-point increase in Nigeria
Healthcare workers in Cape Town ambivalent about patients who disengage from HIV treatment
Most countries with the greatest burden of HIV still don’t recommend dolutegravir for all
Novel, twice-a-year injected drug suppresses multidrug-resistant HIV in most patients on failing therapy
New predictors for peripheral neuropathy found in study of people living with HIV
